| 000 | 01162 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250514063656.0 | ||
| 264 | 0 | _c20040220 | |
| 008 | 200402s 0 0 eng d | ||
| 022 | _a0959-4973 | ||
| 024 | 7 |
_a10.1097/00001813-200304000-00001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTaraboletti, Giulia | |
| 245 | 0 | 0 |
_aIDN 5390: a new concept in taxane development. _h[electronic resource] |
| 260 |
_bAnti-cancer drugs _cApr 2003 |
||
| 300 |
_a255-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBridged-Ring Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aNeoplasms _xblood supply |
| 650 | 0 | 4 |
_aTaxoids _xadministration & dosage |
| 700 | 1 | _aMicheletti, Gianluca | |
| 700 | 1 | _aGiavazzi, Raffaella | |
| 700 | 1 | _aRiva, Antonella | |
| 773 | 0 |
_tAnti-cancer drugs _gvol. 14 _gno. 4 _gp. 255-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00001813-200304000-00001 _zAvailable from publisher's website |
| 999 |
_c12472342 _d12472342 |
||